Cargando…
Proximal Tubule mTORC1 Is a Central Player in the Pathophysiology of Diabetic Nephropathy and Its Correction by SGLT2 Inhibitors
Diabetic kidney disease (DKD) increases the risk for mortality and is the leading cause of end-stage renal disease. Treatment with sodium-glucose cotransporter 2 inhibitors (SGLT2i) attenuates the progression of DKD, especially in patients with advanced kidney disease. Herein, we show that in diabet...
Autores principales: | Kogot-Levin, Aviram, Hinden, Liad, Riahi, Yael, Israeli, Tal, Tirosh, Boaz, Cerasi, Erol, Mizrachi, Ernesto Bernal, Tam, Joseph, Mosenzon, Ofri, Leibowitz, Gil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397516/ https://www.ncbi.nlm.nih.gov/pubmed/32726619 http://dx.doi.org/10.1016/j.celrep.2020.107954 |
Ejemplares similares
-
Mapping the metabolic reprogramming induced by sodium-glucose cotransporter 2 inhibition
por: Kogot-Levin, Aviram, et al.
Publicado: (2023) -
Inhibition of mTORC1 by ER stress impairs neonatal β-cell expansion and predisposes to diabetes in the Akita mouse
por: Riahi, Yael, et al.
Publicado: (2018) -
Opposite physiological and pathological mTORC1-mediated roles of the CB1 receptor in regulating renal tubular function
por: Hinden, Liad, et al.
Publicado: (2022) -
Glucose Amplifies Fatty Acid-Induced Endoplasmic Reticulum Stress in Pancreatic β-Cells via Activation of mTORC1
por: Bachar, Etti, et al.
Publicado: (2009) -
Renal Proximal Tubule Cell Cannabinoid-1 Receptor Regulates Bone Remodeling and Mass via a Kidney-to-Bone Axis
por: Baraghithy, Saja, et al.
Publicado: (2021)